Mothers and CareGivers Investing in Children
Launched by UNIVERSITY OF TEXAS AT AUSTIN · Nov 22, 2019
Trial Information
Current as of September 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The incidence of childhood obesity in the United States has steadily increased over the past 30 years, but has begun to level off in recent years. Children from minority groups may be disproportionately affected, such that Hispanic and non-Hispanic Black children have greater weight for recumbent length compared to White children. Similarly, socioeconomic status (SES) may affect child weight status. Epidemiological evidence indicates that obesity may transmitted across multiple generations. Genetics are a factor in determining weight status, but parents are largely responsible for regulatin...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Mothers with babies aged 4 to 5 months
- • Other caregivers assisting the mother with the baby.
- • Babies aged 4 to 5 months
- Exclusion Criteria:
- • Babies with metabolic or feeding issues.
- • Mothers younger than 16 years of age.
About University Of Texas At Austin
The University of Texas at Austin, a leading research institution, is dedicated to advancing knowledge and innovation in the field of healthcare through rigorous clinical trials. Known for its commitment to scientific excellence, the university leverages its diverse expertise and cutting-edge facilities to conduct research that addresses critical health challenges. Collaborating with a multidisciplinary team of researchers, clinicians, and students, the University of Texas at Austin aims to translate scientific discoveries into effective treatments and interventions, ultimately enhancing patient outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Austin, Texas, United States
Austin, Texas, United States
Patients applied
Trial Officials
Deborah Jacobvitz, PhD
Principal Investigator
University of Texas at Austin
Elizabeth Widen, PhD, RD
Principal Investigator
University of Texas at Austin
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials